Xinge Du | Architectural Design and Theory | Research Excellence Award

Published on by Academic Achievements

Dr. Xinge Du | Architectural Design and Theory | Research Excellence Award

Tianjin University | China

Dr. Xinge Du (Dylan) is a Ph.D. candidate in Architecture at Tianjin University, specializing in green building, low-carbon campus planning, and building performance optimization. His research integrates sustainable design principles with advanced simulation and BIM technologies to develop practical solutions for energy-efficient built environments. He previously earned his Master’s and Bachelor’s degrees from Taiyuan University of Technology, where he received multiple academic scholarships and honors. Du has published in high-impact journals such as Scientific Reports and Sustainability, contributing innovative frameworks for low-carbon building retrofits and campus design. Actively involved in industry-linked projects, he has led architectural designs incorporating photovoltaic systems and passive energy strategies. His award-winning work in rural housing and campus retrofitting demonstrates a strong commitment to sustainable development and real-world architectural innovation.

Citation Metrics (Scopus)

9

6

3

0

Citations
6

Documents
2

h-index
2

🟦 Citations 🟥 Documents 🟩 h-index

Featured Publications

 

 

Yu-Jin Kim | Agricultural and Biological Sciences | Research Excellence Award

Published on by Academic Achievements

Prof. Dr. Yu-Jin Kim | Agricultural and Biological Sciences | Research Excellence Award

Pusan National University | South Korea

Dr. Yu-Jin Kim is an Associate Professor in the Department of Life Science and Environmental Biochemistry at Pusan National University. She specializes in plant molecular biology, with a focus on functional genomics, reproductive development, and secondary metabolite biosynthesis in crops such as rice and ginseng. Dr. Kim earned her Ph.D. in Herb Genetic Engineering from Kyung Hee University, graduating with outstanding academic performance. Her research has significantly advanced understanding of pollen tube growth, male sterility mechanisms, and stress responses in plants. She has published extensively in high-impact SCI(E) journals and contributed to internationally recognized collaborations. In 2026, she was elected as a member of the Young Korean Academy of Science and Technology (Y-KAST), reflecting her growing influence in plant science and biotechnology research.

Citation Metrics (Scopus)

6000

4500

3000

1500

0

Citations
5,991

Documents
128

h-index
36

🟦 Citations 🟥 Documents 🟩 h-index

Featured Publications

 

 

Elena Dolgikh | Agricultural and Biological Sciences | Research Excellence Award

Published on by Academic Achievements

Dr. Elena Dolgikh | Agricultural and Biological Sciences | Research Excellence Award

ARRIAM | Russia

Dr. Elena Anatolyevna Dolgikh is a leading scientist in plant–microbe interactions and molecular plant biology, currently serving as Head of the Laboratory of Signal Regulation at the All-Russia Research Institute for Agricultural Microbiology, Russia. Her research focuses on rhizobium–plant symbiosis, signal transduction, nodulation, and hormonal regulation in legumes. With over 75 publications indexed in WoS and Scopus, many in Q1 journals, she has made significant contributions to understanding molecular mechanisms underlying nitrogen-fixing symbiosis. Dr. Dolgikh has led nationally and internationally funded projects and collaborated with prominent institutions in the USA, France, and the Netherlands through NATO and FEMS fellowships. A laureate of the Russian Federation Government Prize in Science and Technology, her work has strong societal impact in advancing sustainable agriculture, improving crop productivity, and supporting environmentally friendly biofertilizer development.

Featured Publications

Cereblon induces G3BP2 neosubstrate degradation using molecular surface mimicry
– Nature Structural and Molecular Biology (2026) | Citations: 1

 

Annamaria Pratelli | Veterinary Medicine | Research Excellence Award

Published on by Academic Achievements

Prof. Dr. Annamaria Pratelli | Veterinary Medicine | Research Excellence Award

Università degli Studi di Bari – Dipartimento di Medicina Veterinaria | Italy

Prof. Annamaria Pratelli is a Full Professor of Infectious Diseases of Animals at the University of Bari, Italy, and a globally recognized expert in veterinary virology and coronavirus research. She has been listed among the World’s Top 2% Scientists by Stanford University (2022 and 2025) and has contributed significantly to the study of animal coronaviruses and zoonotic diseases. With over 205 peer-reviewed publications, an H-index of 33, and more than 3,100 citations (Scopus, 2026), her work spans viral pathogenesis, epidemiology, and antiviral strategies. She has led multiple nationally funded research projects and actively contributed to SARS-related task forces in collaboration with national health authorities. Prof. Pratelli serves on several international editorial boards and has extensive experience in scientific evaluation and governance, with impactful contributions to One Health and global infectious disease research.

Citation Metrics (Scopus)

3500

2500

1500

500

0

Citations
3,125

Documents
123

h-index
34

🟦 Citations 🟥 Documents 🟩 h-index

Featured Publications

Evidence for evolution of canine parvovirus type 2 in Italy
– Journal of General Virology (2001) | Citations: 854

A canine parvovirus mutant is spreading in Italy
– Journal of Clinical Microbiology (2004) | Citations: 180

Genetic diversity of a canine coronavirus detected in pups with diarrhoea in Italy
– Journal of Virological Methods (2003) | Citations: 155

Development of a nested PCR assay for the detection of canine coronavirus
– Journal of Virological Methods (1999) | Citations: 135

 

Aishwarya R Kurdekar | Pharmaceutical Science | Best Researcher Award

Published on by Academic Achievements

Ms. Aishwarya R Kurdekar |  Pharmaceutical Science | Best Researcher Award

Bapuji pharmacy college | India
Ms. Aishwarya R. Kurdekar is a dedicated Pharmacology Research Scholar at Bapuji Pharmacy College, specializing in anticancer pharmacology, natural product drug discovery, and oxidative stress mechanisms. She holds an M.Pharm in Pharmacology and has contributed to advancing plant-based therapeutic research through both experimental and computational approaches. Her notable publication in Cell and Tissue Biology (Springer Nature) explores the antioxidant and anticancer potential of Argemone mexicana seed extract using HepG2 liver cancer cell lines. Her research integrates in-vitro studies with LC-MS profiling, network pharmacology, and molecular docking to identify bioactive compounds and molecular targets. She has actively collaborated with academic researchers and presented her work at national conferences, earning recognition including a Best E-Poster Award. Her ongoing research focuses on pancreatic cancer (PANC-1) cell lines, aiming to develop safer, effective anticancer strategies with societal impact.

Featured Publications

 

Ravi Maharjan | Pharmaceutics | Best Researcher Award

Published on by Academic Achievements

Dr. Ravi Maharjan | Pharmaceutics | Best Researcher Award

Dr. Ravi Maharjan | Pharmaceutics | Assistant Research Professor at Yonsei University | South Korea

Pharmaceutics is the foundation of Dr. Ravi Maharjan’s distinguished career as a research professor at Yonsei University, Korea, where he has been at the forefront of integrating AI/ML and Digital Twin technologies to revolutionize biopharmaceutical manufacturing, particularly in mRNA and siRNA-based lipid nanoparticle (LNP) vaccine development. Dr. Ravi Maharjan earned his PhD in Pharmaceutics and has since developed a deep expertise in biopharmaceutical process optimization, continuous manufacturing, lyophilization, stabilization strategies, and innovative delivery approaches targeting ocular and brain tissues. His professional experience spans extensive teaching, mentoring, and research leadership roles, where he has guided national and international collaborations with universities, pharmaceutical companies, and research institutions, including Pusan National University, CHA University, RCPE, RNAAnalytics Austria, and IMDEA Spain, demonstrating his ability to bridge academic research with industrial applications. Dr. Ravi Maharjan’s research interests focus on applying AI/ML algorithms for predictive modeling of complex pharmaceutical processes, optimizing formulations, ensuring protein stability, and enhancing the physical and biological stability of therapeutics. His work integrates pharmaceutics, process analytical technologies (PAT), quality by design (QbD), experimental design (DOE), and computational modeling to advance next-generation biopharmaceutical platforms. Among his key research skills are data-driven formulation design, predictive modeling, digital twin deployment, computational optimization of LNP delivery, lyophilized formulation screening, molecular simulation, process monitoring, and the translation of lab-scale research into continuous manufacturing systems. Dr. Ravi Maharjan has an impressive record of scholarly contributions, including over 23 SCIE Q1 publications, two books, two book chapters, more than 115 peer-review assignments, over 30 conference presentations, and eight invited talks. He has served as associate editor for Pharmaceutical Science and Technology (USA), editorial board member for Scientific Reports (Nature Portfolio, UK), Pharmaceutics (Switzerland), and Current Pharmaceutical Biotechnology (UAE), as well as conference organizer for multiple international events. His awards and honors recognize his contributions to both fundamental pharmaceutics and applied biopharmaceutical manufacturing, highlighting his excellence in research innovation and mentorship. Dr. Ravi Maharjan has demonstrated outstanding ability to secure funding, lead interdisciplinary projects, and foster scientific collaboration across countries and institutions, contributing to the advancement of mRNA and siRNA therapeutics, the optimization of excipients, and the improvement of drug delivery systems. His work on digital twins and AI/ML-driven process optimization has paved the way for predictive control in continuous manufacturing, ensuring reproducibility, efficiency, and quality in pharmaceutical production. In conclusion, Dr. Ravi Maharjan embodies the integration of scientific innovation, computational methods, and practical pharmaceutics expertise, making significant impacts in biopharmaceutical sciences, while continuing to mentor the next generation of researchers, drive technological innovation, and advance knowledge in AI-assisted pharmaceutical development.

Profile: Google Scholar

Featured Publications 

  1. Tripathi, J., Thapa, P., Maharjan, R., & Jeong, S. H. (2019). Current state and future perspectives on gastroretentive drug delivery systems. Citations: 246
  2. Maharjan, R., Hada, S., Lee, J. E., Han, H. K., Kim, K. H., Seo, H. J., Foged, C., … (2023). Comparative study of lipid nanoparticle-based mRNA vaccine bioprocess with machine learning and combinatorial artificial neural network-design of experiment approach. Citations: 48
  3. Maharjan, R., Kim, K. H., Lee, K., Han, H. K., & Jeong, S. H. (2024). Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost/Bayesian method and ensemble model approaches. Citations: 44
  4. Maharjan, R., & Jeong, S. H. (2020). High shear seeded granulation: Its preparation mechanism, formulation, process, evaluation, and mathematical simulation. Citations: 37
  5. Bhujel, R., Maharjan, R., Kim, N. A., & Jeong, S. H. (2021). Practical quality attributes of polymeric microparticles with current understanding and future perspectives. Citations: 29
  6. Maharjan, R., Lee, J. C., Lee, K., Han, H. K., Kim, K. H., & Jeong, S. H. (2023). Recent trends and perspectives of artificial intelligence-based machine learning from discovery to manufacturing in biopharmaceutical industry. Citations: 28
  7. Kim, K. H., Lee, J. E., Lee, J. C., Maharjan, R., Oh, H., Lee, K., Kim, N. A., & Jeong, S. H. (2023). Optimization of HPLCCAD method for simultaneous analysis of different lipids in lipid nanoparticles with analytical QbD. Citations: 17

 

Assoc. Prof. Dr. Iulia Ioan | Medicine | Women Researcher Award

Published on by Academic Achievements

Assoc. Prof. Dr. Iulia Ioan | Medicine | Women Researcher Award

Assoc. Prof. Dr. Iulia Ioan | Medicine – University Hospital of Nancy, France

Dr. Iulia Ioan is a dedicated researcher specializing in pediatric respiratory medicine and sleep disorders. Her work focuses on advancing the understanding and clinical management of respiratory oscillometry, asthma, and obstructive sleep apnea in children and adults. Over recent years, she has established herself as a respected figure in her field, contributing to multidisciplinary collaborations that bridge clinical practice and functional respiratory research. Her continuous output of high-quality research articles and reviews reflects her commitment to improving respiratory health outcomes through innovative diagnostics and treatment strategies.\

Profile Verified:

ORCID | Scopus | Google Scholar

Education:

Dr. Ioan’s academic journey includes advanced medical and scientific training culminating in an MD and PhD, equipping her with a solid foundation in clinical medicine and biomedical research. Her specialized education in functional respiratory explorations has enabled her to develop expertise in pediatric respiratory function testing and clinical sleep medicine, which underpins her research endeavors.

Experience:

With substantial experience in clinical and research settings, Dr. Ioan currently serves at the Service d’Explorations Fonctionnelles Pédiatriques, Hôpital d’Enfants, CHRU de Nancy. Her role involves both direct patient care and leading research projects focused on pediatric respiratory diseases and sleep disorders. Over the years, she has honed skills in polysomnography, respiratory mechanics, and the evaluation of airway diseases, collaborating with national and international teams. Her involvement in translational research facilitates the implementation of novel diagnostic tools into routine clinical practice.

Research Interest:

Dr. Ioan’s research interests encompass respiratory oscillometry, pediatric asthma, sleep apnea syndromes, and the impact of environmental factors such as tobacco smoke on respiratory health. She explores the clinical applications of respiratory function testing technologies and their relevance in diagnosing and managing obstructive airway diseases. Additionally, her work addresses the epidemiology and treatment effectiveness of severe allergic asthma and sleep-related breathing disorders, contributing valuable insights into pediatric pulmonology and sleep medicine.

Awards:

While specific awards are not listed, Dr. Ioan’s profile demonstrates recognition through citations and sustained research output. Her work’s impact on clinical practice and respiratory medicine positions her as a strong candidate for research awards celebrating female scientists. Continued excellence in publication, collaboration, and clinical innovation further strengthens her candidacy for prestigious honors within respiratory and pediatric research communities.

Selected Publications:

  1. 🌬️ “Technical standards for respiratory oscillometry,” European Respiratory Journal, 2020. (Cited by 578) – This pivotal article defines technical guidelines widely used in respiratory function testing.
  2. 💤 “Clinical significance and applications of oscillometry,” European Respiratory Review, 2022. (Cited by 168) – A comprehensive review highlighting oscillometry’s role in respiratory disease assessment.
  3. 🌟 “Asthma and obstructive sleep apnoea in adults and children – an up-to-date review,” Sleep Medicine Reviews, 2022. (Cited by 65) – Integrates current knowledge on the overlap between asthma and sleep apnea.
  4. 🚭 “The impact of tobacco smoking on adult asthma outcomes,” International Journal of Environmental Research and Public Health, 2021. (Cited by 59) – Examines how smoking exacerbates asthma symptoms and treatment outcomes.
  5. 🛌 “Feasibility of parent-attended ambulatory polysomnography in children with suspected obstructive sleep apnea,” Journal of Clinical Sleep Medicine, 2020. (Cited by 31) – Demonstrates the practicality of home-based sleep studies for children.
  6. 🌿 “Real-life effectiveness of benralizumab, mepolizumab and omalizumab in severe allergic asthma associated with nasal polyps,” Clinical Reviews in Allergy & Immunology, 2023. (Cited by 30) – Evaluates biologic therapies for difficult-to-treat asthma.
  7. 🧒 “What is chronic cough in children?” Frontiers in Physiology, 2014. (Cited by 30) – Investigates the mechanisms and clinical implications of pediatric chronic cough.

Conclusion:

Dr. Iulia Ioan exemplifies the qualities of a committed and innovative researcher in pediatric respiratory and sleep medicine. Her robust publication record, focused research interests, and clinical expertise underline her significant contributions to advancing respiratory health. Dr. Ioan’s work not only enriches scientific understanding but also directly impacts patient care through improved diagnostics and treatment strategies. Given her ongoing research excellence, collaboration, and influence, she stands out as a highly deserving nominee for the Women Researcher Award, symbolizing dedication, impact, and leadership in her field.

 

 

 

Eni Bushi | Pharmaceutical | Best Review Paper Award-7740

Published on by Academic Achievements

Dr. Eni Bushi | Pharmaceutical | Best Review Paper Award

Dr. Eni Bushi | Pharmaceutical – PhD student at University of Medicine Tirana, Albania

Eni Bushi (Beçi) is a dynamic pharmaceutical professional and researcher whose work bridges academia and the pharmaceutical industry. With extensive experience in pharmaceutical technology, quality assurance, and public health, she has made significant contributions both as a researcher and a leader in pharmaceutical practice. As the current Head of the Quality Assurance Department at Profarma sh.a. and a faculty member at the University of Medicine in Tirana, she plays a crucial role in shaping drug development standards and mentoring emerging professionals. A member of key scientific bodies such as NanoAlb and the Academy of Pharmacy “Eureka,” she exemplifies a strong commitment to advancing pharmaceutical knowledge through rigorous scientific inquiry and industry innovation.

Profile Verified

Scopus

Education

Eni Bushi holds a Master of Science in Pharmaceutical Sciences from the University of Medicine, Tirana, where she graduated with a perfect GPA and defended a thesis focused on prescription practices among elderly patients. Demonstrating her multidisciplinary outlook, she pursued a Master of Business Administration (MBA) at the University of New York Tirana, concentrating on healthcare management, with a thesis on Lean implementation in health systems. Currently, she is a PhD candidate in Pharmaceutical Technology at the same university, focusing on innovative semisolid formulations and their stability. Her academic journey has been enhanced by international certifications and professional development courses in nanotechnology, analytical validation, and Good Laboratory Practices.

Experience

Professionally, Eni Bushi has cultivated a strong career trajectory from community pharmacy to pharmaceutical manufacturing and research. Starting as a community pharmacist, she developed early experience in patient care and medication management. She then transitioned to Profarma sh.a., where she rose from Specialist to Head of the Quality Assurance Department, leading regulatory compliance, validation processes, and interdepartmental coordination. Simultaneously, she has served as a laboratory assistant and research mentor at the University of Medicine in Tirana. Her industry-academic hybrid role enables her to influence both pharmaceutical practice and education, while also fostering research innovation in drug development and regulatory science.

Research Interest

Eni Bushi’s research interests center on pharmaceutical technology, quality systems, antimicrobial resistance, and health systems improvement. Her current doctoral research focuses on semisolid drug formulations, with an emphasis on their physicochemical stability and comparative efficacy. She is particularly interested in integrating nanotechnology into drug delivery systems, and has pursued specialized training in nanomedicine. Her previous studies have explored the knowledge and behavior surrounding antibiotic use, as well as Lean strategies in healthcare environments. These interdisciplinary themes reflect her goal of advancing public health outcomes through innovation in drug formulation and pharmaceutical services.

Awards

Throughout her academic and professional journey, Eni Bushi has received recognition for her academic excellence and leadership. She was awarded the “Excellent Student” distinction by the University of Tirana’s Rectorate and has been consistently invited to contribute to international forums and scientific conferences. Her nomination for the Best Review Paper Award is underpinned by a record of impactful publications, academic mentorship, and a leadership role in pharmaceutical quality assurance.

Selected Publications

  1. 📘 Evaluation of the Knowledge, Attitude and Public Awareness about the Use of Antibiotic and Antibiotic Resistance in Albania (2024) – Indian Journal of Pharmaceutical Education and Research. Cited by 6 articles.
  2. 🧴 Formulation, Preparation and Evaluation of a Natural Cosmetic Product (2023) – Albanian Journal of Medical and Health Sciences. Cited by 3 articles.
  3. 🏥 Using Expert Consensus to Evaluate the Readiness Factors of Lean Implementation in Healthcare (2022) – International Journal of Scientific Research and Management. Cited by 9 articles.
  4. 👵 Prevalence and Factors Associated with Potentially Inappropriate Prescriptions among Older Patients at Hospital Discharge in Albania (2016) – Journal of Evaluation in Clinical Practice. Cited by 28 articles.
  5. 🧪 Theoretical Aspects of the Application of “Quality by Design” Approach in Drug Formulation (2025, Thesis Supervision) – Unpublished.
  6. 💊 Prevalence Assessment and Analysis of Self-Reported Use of Stimulant and Sedative Drugs among University Students (2023, Thesis Supervision) – University of Medicine, Tirana.
  7. 🧬 Analysis on the Level of Knowledge, Attitude, and Public Awareness Towards the Use of Antibiotics and Antimicrobial Resistance (2021, Thesis Supervision) – University of Medicine, Tirana.

Conclusion

Eni Bushi demonstrates a strong and evolving profile as a researcher, practitioner, and academic leader in the field of pharmaceutical sciences. Her combined background in pharmacy, business management, and pharmaceutical technology positions her uniquely to contribute to transformative change in drug formulation, health policy, and quality assurance. Her dedication to innovation, public health, and regulatory science makes her a highly deserving candidate for the Best Review Paper Award. Her work not only exemplifies academic excellence but also provides practical value to both the pharmaceutical industry and healthcare systems in Albania and beyond.

Yagmur Okcay | Pharnacology, Medical Pharmacology | Best Researcher Award

Published on by Academic Achievements

Ms.Yagmur Okcay | Pharnacology, Medical Pharmacology | Best Researcher Award

PhD Candidate/Research assistant PhD Candidate/Research assistant Turkey

Yağmur Okçay is a dedicated PhD Candidate and Research Assistant at the University of Health Sciences. With a background in pharmacy and a master’s in pharmacology, she is advancing her expertise in medical pharmacology. Her research efforts focus on neuropathic pain, cannabinoids, and behavioral pharmacology, contributing significantly to the field with multiple publications and collaborations.

profile

ORCiD

Education 🎓

Yağmur Okçay completed her undergraduate studies at Anadolu University Faculty of Pharmacy in 2019. She then pursued a master’s degree in Pharmacology. Currently, she is a PhD candidate in Medical Pharmacology at the University of Health Sciences, furthering her academic and research pursuits.

Experience 🏫

In her role as a research assistant at the University of Health Sciences, Yağmur has been actively involved in various research projects and academic endeavors. Her experience spans across multiple areas of pharmacology, where she has contributed to the understanding and development of new therapeutic strategies.

Research Interests 🔬

Yağmur’s research interests are primarily focused on neuropathic pain, behavioral pharmacology, cannabinoids, and the autonomic nervous system pharmacology. Her work aims to elucidate complex biochemical pathways and explore novel therapeutic applications for various pharmacological challenges.

Awards 🏆

Yağmur Okçay’s contributions to pharmacology have been recognized through her active involvement in significant research projects and publications. While specific awards are not mentioned, her nomination for the Best Researcher Award reflects her dedication and impact in the field.

Publications 📄

  1. Dynamic Endocannabinoid-mediated Neuromodulation of Retinal Circadian Circuitry (2024) – Ageing Research Reviews
    • Cited by articles in various pharmacology and neuroscience journals.
  2. Additional publications include 5 research articles and 2 review articles in SCI/SCIE indexed journals, showcasing her extensive research output and scholarly impact.

Abdulfatai Ajiboye | medicinal Chemistry | Best Researcher Award

Published on by Academic Achievements

Dr. Abdulfatai Ajiboye | medicinal Chemistry | Best Researcher Award

Lecturer, Kwara State University, Malete, Nigeria

Dr. Ajiboye Abdulfatai Temitope is a distinguished scholar and lecturer in the Department of Chemistry and Industrial Chemistry at Kwara State University, Malete, Nigeria. With extensive experience in natural products and medicinal chemistry, Dr. Ajiboye has significantly contributed to the field through his research on bioactive compounds from natural sources. He has held various academic positions, fostering a strong commitment to teaching and community development. 🌟📚

Profile

Google Scholar

Education🎓

Dr. Ajiboye earned his Ph.D. in Chemistry, specializing in Natural Products/Medicinal Chemistry and Organic Chemistry, from the University of Lagos, Nigeria, in December 2021. He also holds an M.Sc. in Chemistry from the University of Ilorin (2014) and a B.Sc. (Honours) in Chemistry from the same institution (2007). 🎓🔬

Experience🏫

Dr. Ajiboye is currently a Lecturer I at Kwara State University, a role he has held since 2022. He previously served as Lecturer II (2017-2022) and Assistant Lecturer (2014-2017) at the same institution. His expertise includes molecular networking, virtual screening, and the design and synthesis of bioactive organic molecules. 🌐🧪

Research Interests📚

Dr. Ajiboye’s research focuses on isolating and characterizing bioactive compounds from natural sources, designing and synthesizing small organic molecules with biological properties, and employing molecular networking and virtual screening techniques to identify novel compounds. His work also includes studying the antioxidant, antimicrobial, and antihyperglycemic properties of phytochemicals. 🌿🔍

Awards🏆

Dr. Ajiboye has been recognized for his significant contributions to chemistry and medicinal plant research. He is a member of esteemed professional societies, including the Society for Medicinal Plants and Economic Development (SOMPED) and the American Society for Pharmacognosy (ASP). 🏆🏅

Publications

Extraction of Phenolic Compounds from Some Ayurvedic Botanicals and Evaluation of Their Antibacterial and Antiviral Properties Using Bioinformatics Approaches (2024). Computational Approaches in Biotechnology and Bioinformatics. Link 🌐

Phytochemicals and Enzymes Inhibitory Potentials Of Leaves and Root Barks of Sarcocephalus latifolius (Smith): In Vitro and in Silico Investigations (2024). SSRN. Link 📄

Physicochemical Analyses of Coconut (Cocos nucifera L.) Oil Obtained by Solvent (Aqueous and n-hexane) Extraction Methods (2024). International Journal of Research in Pharmacy and Allied Science (IJRPAS). 🌍

Synthesis, Characterization and α-amylase Inhibition Study of Substituted Schiff Base and its Metal Complexes (2023). IJRPAS. 📘

Epigenetic Oncogenesis, Biomarkers and Emerging Chemotherapeutics for Breast Cancer (2022). BBA-Gene Regulatory Mechanisms. Link 🔬